A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb
- 1 September 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (10) , 1668-1673
- https://doi.org/10.1016/0959-8049(96)00170-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases from malignant melanomaBritish Journal of Surgery, 1995
- A single centre prospective study of adjuvant isolated limb perfusion (ILP)Melanoma Research, 1993
- The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanomaBritish Journal of Cancer, 1992
- In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon-γ and melphalan in isolation perfusionWorld Journal of Surgery, 1992
- Objective Regression of Unexcised Melanoma in-Transit Metastases After Hyperthermic Isolation Perfusion of the Limbs with MelphalanPublished by Springer Nature ,1983
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982
- Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbsPublished by Elsevier ,1981
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- A Retrospective Study of Regional Perfusion for MelanomaArchives of Surgery, 1976
- Chemotherapy of CancerAnnals of Surgery, 1958